TNFSF13B and metabolic dysfunction-associated steatohepatitis: To explore the role of BAFF in liver fibrosis in NASH, we established a new mouse model using HFHCD/CCl4-induced liver injury (Figure 1a), which was modified from previous reports [17,18].